BioAdaptives, Inc.

BDPT · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$899-$712-$896-$1,050
Dep. & Amort.$2$28$62$134
Deferred Tax$0$0$0$141
Stock-Based Comp.$209$0$0$164
Change in WC$77$20$182$235
Other Non-Cash$362$440$424$217
Operating Cash Flow-$250-$224-$227-$159
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$32$80$170$237
Stock Issued$294$178$522$857
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$294$1$0$0
Financing Cash Flow$326$259$170$237
Forex Effect$0$0-$0-$0
Net Chg. in Cash$77$35-$58$78
Supplemental Information
Beg. Cash$61$25$83$5
End Cash$137$61$25$83
Free Cash Flow-$250-$224-$227-$159
BioAdaptives, Inc. (BDPT) Financial Statements & Key Stats | AlphaPilot